You are here

  • Home
  • Archive
  • Volume 9, Issue 12
  • Mapping the preclinical to clinical evidence and development trajectory of the oncolytic virus talimogene laherparepvec (T-VEC): a systematic review

Article metrics

Article menu

Download PDFPDF

Epidemiology
Original research
Mapping the preclinical to clinical evidence and development trajectory of the oncolytic virus talimogene laherparepvec (T-VEC): a systematic review

 

Online download statistics by month:

Online download statistics by month: December 2019 to April 2021

AbstractFullPdf
Dec 2019456442126
Jan 202027326651
Feb 202018116946
Mar 202015314826
Apr 202010410227
May 2020898719
Jun 2020666413
Jul 2020515018
Aug 2020585013
Sep 2020897526
Oct 2020403514
Nov 2020544817
Dec 2020423319
Jan 2021413513
Feb 2021605319
Mar 2021605729
Apr 2021423915
Total18591753491